NASDAQ:QLGN
Delisted

Qualigen Therapeutics Stock Signals

etoro logo Buy QLGN
*Your capital is at risk
$3.21
+0 (+0%)
At Close: Feb 17, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Qualigen Therapeutics Inc.

General

Signal Type Signal Value Data
Score 0.000 59 days ( 0 %
Last Price $3.21 0 %
Performance History
7 Days
$3.21 $3.21
0%
30 Days
$3.21 $3.21
0%
12 Mos
$3.65 $3.21
-12.05%

4/18

Active Buy Signals

Specific Signals

Short Term
Net score: 45.27
Signal Type Signal Value Importance Data
High / Low N/A Very Low $3.21 - $3.21
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Feb 13, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Dec 02, 2025 - 52 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Buy Medium Nov 25, 2025 - 56 days
Short/Long MA 3 mos Buy Medium Nov 25, 2025 - 56 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 25.98
Signal Type Signal Value Importance Data
Trend - 12 mos -3.51 % Very High Width: 371.88 %
Pred. range - 12 mos $1.21 - $5.72 High -62.23 % - 78.22 %
Short MA 12 mos Buy Very High Nov 14, 2025 - 63 days
Long MA 12 mos Sell Very High Jan 13, 2026 - 24 days
Short/Long MA 12 mos Sell Very High Jan 13, 2026 - 24 days
Pivot Long Sell Low Feb 13, 2026 - 2 days
RSI Long Pivot Signal Sell Low Dec 11, 2025 - 45 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT QUALIGEN THERAPEUTICS INC.
Qualigen Therapeutics
Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that block...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE